Pages that link to "Q31141962"

The following pages link to Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study (Q31141962):

Displaying 20 items.

• Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon β-1a: an observational study SKORE (Q33589940) (← links)
• Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis (Q35083857) (← links)
• Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies (Q37027697) (← links)
• PLGA micro and nanoparticles in delivery of peptides and proteins; problems and approaches. (Q38183886) (← links)
• Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study (Q38377029) (← links)
• Immunomodulatory treatments and cognition in MS. (Q38942635) (← links)
• Physical activity and cognitive function in adults with multiple sclerosis: an integrative review (Q38986441) (← links)
• The effects of video-game training on broad cognitive transfer in multiple sclerosis: A pilot randomized controlled trial (Q39020772) (← links)
• Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor (Q39396414) (← links)
• Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery (Q47935971) (← links)
• Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis (Q47978062) (← links)
• Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial (Q48009972) (← links)
• Cognition in multiple sclerosis. (Q49972473) (← links)
• Gender effects on treatment response to interferon-beta in multiple sclerosis. (Q51114281) (← links)
• Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily. (Q53615466) (← links)
• Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation (Q57802279) (← links)
• The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results (Q58755233) (← links)
• Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview (Q64073642) (← links)
• Anti-inflammatory and cognitive effects of interferon-β1a (IFNβ1a) in a rat model of Alzheimer's disease (Q64255119) (← links)
• Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a. (Q64988430) (← links)